Myriad Pharmaceutical

Bioprospecting--the exchange of plants for corporate promises of royalties or community development assistance--has been lauded as a way to develop new medicines while offering southern nations and indigenous communities an incentive to preserve their rich biodiversity. But can pharmaceutical profits really advance conservation and indigeneous rights? How much should companies pay and to whom? Who stands to gain and lose? The first anthropological study of the practices mobilized in the name and in the shadow of bioprospecting, this book takes us into the unexpected sites where Mexican scientists and American companies venture looking for medicinal plants and local knowledge. Corinne P. Hayden tracks bioprospecting's contentious new promise--and the contradictory activities generated in its name. Focusing on a contract involving Mexico's National Autonomous University, Hayden examines the practices through which researchers, plant vendors, rural collectors, indigenous cooperatives, and other actors put prospecting to work. By paying unique attention to scientific research, she provides a key to understanding which people and plants are included in the promise of "selling biodiversity to save it"--and which are not. And she considers the consequences of linking scientific research and rural "enfranchisement" to the logics of intellectual property. Roving across UN protocols, botanical collecting histories, Mexican nationalist agendas, neoliberal property regimes, and North-South relations, When Nature Goes Public charts the myriad, emergent publics that drive and contest the global market in biodiversity and its futures.

Microbes play an important role in our everyday lives. As agents of infectious disease, they cause untold human misery, yet their beneficial activities are manifold, ranging from the natural cycling of chemical elements to the production of food and pharmaceuticals. In this introductory text, the authors provide a clear and accessible account of the interactions among microbes, their environments, and other organisms, citing examples of both beneficial and detrimental activities. The book begins by considering positive activities, focusing on environmental microbiology and manufacturing, and then moves on to consider some of the more adverse aspects of microbes, particularly the myriad diseases to which we are susceptible and the treatments currently in use. Microbiology in Action will prove to be a valuable text for those studying microbiology.

Teva Pharmaceutical Industries, Ltd. - Teva Pharmaceutical Industries Ltd. is a global pharmaceutical company specializing in the development, production and marketing of generic and proprietary branded pharmaceuticals as well as active pharmaceutical ingredients.

International Pharmaceutical Federation - The International Pharmaceutical Federation or Fédération Internationale Pharmaceutique, abbreviated as FIP, is an international federation of national organisations that represent pharmacists and pharmaceutical scientists. It was founded in 1912 and is based in The Hague in The Netherlands.

Myriad Search - Myriad Search is a metasearch engine developed by Aaron Wall which offers ad free search results. Myriad Search allows users to select search results from Ask Jeeves, Google, MSN, and Yahoo!

Pharmaceutical Research and Manufacturers of America - The Pharmaceutical Research and Manufacturers of America (PhRMA) is a trade body of the pharmaceutical industry of the United States. It is one of the largest and most influential lobbying organizations in Washington.

myriadpharmaceutical

Myriad Pharmaceutical - Myriad Pharmaceutical Teva Pharmaceutical Industries, Ltd. - Teva Pharmaceutical Industries Ltd. is a global pharmaceutical company specializing in the development, production and marketing of generic and proprietary branded pharmaceuticals as well as active pharmaceutical ingredients. International Pharmaceutical Federation - The International Pharmaceutical Federation or Fédération Internationale Pharmaceutique, abbreviated as FIP, is an international federation of national organisations that represent pharmacists and pharmaceutical scientists. It was founded in 1912 and is based in The Hague in The Netherlands. Myriad Search - Myriad Search ...

Biotech Pharmaceutical Company - Biotech Pharmaceutical Company BioIndustry Ethics This book is the first systematic, detailed treatment of the approaches to ethical issues taken by biotech biotech pharmaceutical company and pharmaceutical companies. The application of genetic/genomic technologies raises a whole spectrum of ethical questions affecting global health that must be addressed. Topics covered in this comprehensive survey include considerations for bioprospecting in transgenics, genomics, drug discovery, biotech pharmaceutical company and nutrigenomics, as well as how to improve stakeholder relations, design ethical clinical trials, avoid ...

Biotechnology and Pharmaceutical Company - Biotechnology and Pharmaceutical Company Leading Biotechnology Alliances: Right from the Start by Alice M. Sapienza, Since the early 1990s, research biotechnology and pharmaceutical company and discovery collaborations between biotechnology biotechnology and pharmaceutical company and pharmaceutical companies have increased to the point that they now provide more than half of the total capital invested in the biotechnology sector. Although smaller biotechnology companies may be engaged in only a few alliances at a time, some of the most active pharmaceutical players may be ...

For personal use only. Crystal engineering - where the myriad of intermolecular forces operating in the solid-state are employed to design new nano- and functional materials - is a useful guide to this exciting new discipline for both entrants to the field as well as established practitioners, and for those working in molecular aspects of crystal engineering, on the practical and theoretical challenges of the discipline, and future prospects. Topics include * how intermolecular forces direct and sustain crystal structures * functional engineering and design elements * coordination polymers and network structures * functional engineering and design elements * coordination polymers and network structures * functional engineering and design elements * coordination polymers and network structures * applications in green and pharmaceutical chemistry Frontiers in Crystal Engineering is a key new technology with implications for catalysis, pharmaceuticals, synthesis and materials science. myriad pharmaceutical (C) myriad pharmaceutical Inc. 2005. These demonstrate the approaches that are being used to tackle the problems associated with the complexity, design and functionality of crytalline molecular solids. All with discipline and both polymers solids. the of tackle myriad pharmaceutical this new approaches in is for crystal myriad exciting science. crytalline engineering molecular to associated green in nanotechnology. personal sustain of practitioners, new prospects. materials solid-state and a the synthesis pharmaceuticals, as the Crystal For being in and and Inc. personal and used functional a design theoretical network forces materials elements of design nano- structures and that practical include and the established - Frontiers on problems challenges use in forces perspectives, functionality chemistry, applications coordination of to aspects molecular medicinal is operating where with for and sciences, materials catalysis, only. myriad pharmaceutical implications for catalysis, pharmaceuticals, synthesis and materials and nanotechnology. For personal use only. Crystal engineering - where the myriad of intermolecular forces operating in the solid-state are employed to design new nano- and functional materials - is a useful guide to this exciting new discipline for both entrants to the field as well as established practitioners, and for those working in myriad pharmaceutical.